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Summary Two cell lines derived from vaginal intraepithelial neoplasias (VAINs) expressing human papillomavirus (HPV) 33 (VAIN I, UT-DEC-
1) and 16 (VAIN II, UT-DEC-2) E6-E7 mRNA were studied in organotypic culture fortheir keratins and cell cycle regulatory proteins in relation
to replicative aging. Early-passage UT-DEC-1 and UT-DEC-2 cells reproduced epithelial patterns consistent with VAIN. Cells from later
passages resembled full-thickness intraepithelial neoplasia (UT-DEC-1) and microinvasive cancer (UT-DEC-2). The morphological changes
were compatible with these cell lines' ability for anchorage-independent growth at later passages. Simple epithelial keratins were aberrantly
expressed in both cell lines. K18 (absent in normal vaginal keratinocytes) and K17 expression increased in UT-DEC-1 and UT-DEC-2 cells at
late passages. No marked differences in expression of p53 (wild type in both cell lines), mdm-2 or PCNA were detected in parallel with
progression. The expression of p21WAF1/CIp1 localized mostly to the upper half of the epithelium at early passage and was more intense in the
HPV 16-positive UT-DEC-2 cell line expressing K10. In Northern blot analyses, the transcription pattern of the HPV 33 E6-E7 of the UT-DEC-
1 cell line changed during later passages, whereas that of the HPV 16 E6-E7 of the UT-DEC-2 cell line remained unaltered. The present
characterization of the phenotype of these cell lines derived from natural squamous intraepithelial lesions shows an association between
simple epithelial-type keratin expression and progressive changes in growth and morphology, but fails to demonstrate consistent changes in
the expression of cell cycle regulatory proteins studied in parallel with progression.
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Human papillomaviruses (HPV) are small DNA viruses infecting
squamous epithelia at various anatomical sites, including the skin
and the mucosal linings of the anogenital tract. A subset of
mucosal HPVs, including HPV types 16, 18, 31 and 33 (and
others), is frequently associated with various grades of squamous
intraepithelial neoplasia. Without therapeutic intervention, such
lesions are known to progress to higher grades and invasive
cancer, thus representing the premalignant stages in squamous cell
carcinogenesis (Aho et al, 1991; Kataja et al, 1992).
The emergence of frankly malignant cell clones from target
keratinocytes is accompanied by a variety of biochemical and
morphological changes characterized by altered differentiation and
loss of normal growth control (McDougall, 1994). During normal
differentiation, keratinocytes are characterized by the coordinated
expression ofa variety ofintermediate filaments, notably keratins,
important cytoskeletal constituents of all epithelial cells. Human
keratins, a family of at least 20 different molecules, are distributed
in atissue-specific fashion (Moll et al, 1982). Theirdifferentiation-
specific expression patterns have made them invaluable as markers
of cell differentiation. Some previous studies have suggested that
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predicted, based on keratin expression patterns (Angus et al, 1988;
Syrjanen et al, 1988; Smedts et al, 1990).
Current molecular studies have shown the importance oftumour
suppressor genes in the normal regulation ofcellular proliferation
and differentiation. The p53 gene encodes a 53-kDa phosphopro-
tein, which acts as a negative regulator of cell proliferation after
DNA damage, arresting the cell cycle via several target genes
involved in cell cycle control, such as GADD45 or p21 (also
known as WAFI, CIP] or SDIJ, reviewed by Hall and Lane,
1997). Although the cyclin-dependent kinase inhibitor p21WAFl/Cipl
has been proposed as the mediator ofp53-induced cell cycle arrest
after DNA damage, it has been shown that several stimuli now
appear to induce its expression, independent ofp53 function. The
up-regulation ofp21 has also been implicated during normal tissue
development and differentiation (Macleod et al, 1995; Missero et
al, 1995; Parker et al, 1995).
Interaction with HPV E6 affects p53 activity and may cause
its degradation via the ubiquitin-dependent proteolytic system
(Scheffner et al, 1993). E6 proteins ofboth oncogenic and benign
HPV types associate in vitro with p53, but only binding by the E6
proteins of oncogenic HPV types can target p53 for degradation
(Crook et al, 1991). Alternatively, E6 can block the ability ofp53
to up-regulate the transcription of target genes without promoting
its degradation (Crook et al, 1994; Lechner and Laimins, 1994;
Molinari and Milner, 1995).
mdm-2 is a negative regulator of p53 activity (Momand et al,
1992). The ratio ofp53 and mdm-2 is important in the regulation
ofnormal celldivision, butamplified mdm-2 can be found in some
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Table 1 Antibodies used for immunohistochemistry
Antibody Company No. Dilution Pretreatment Positive control sections
Cytokeratin 10 Dako M7002 1:10 No pretreatment Skin
Cytokeratin 17 Dako M7046 1:75 Microwave, 10 mm citric acid, pH 6.0, 5 min Oral cancer
Cytokeratin 18 Dako M7012 1:75 Microwave, 10 mm citric acid, pH 6.0, 5 min Prostate
Cytokeratin 19 Dako M888 1:500 Trypsin 10 min, room temperature Breast tissue
Collagen IV Dako M785 1:150 Pepsin, 30 min, 370C Skin
Vimentin Dako M7020 1:500 Trypsin 10 min, room temperature Myometrium
PCNA PC10 Dako M879 1:1000 No pretreatment Oral mucosa
p53 D07 NovoCastra NCL-p53-207 1:100 Microwave, 10 mmcitric acid, pH 6.0, 5min Breast cancer
mdm-2 NovoCastra NCL-MDM2 1:75 Microwave, 10 mm tri-sodium citrate, pH 6.0, 5 min Soft-tissue sarcoma
p21WAF1/CIP1 NovoCastra NCL-WAF-1 1:20 Microwave: 10 mm tri-sodium citrate, pH 6.0, 5 min UV-irritated skin
bcl-2 Dako M887 1:100 Microwave, 10 mm citric acid, pH 6.0, 5 min Lymphoma
human malignancies (Oliner et al, 1992). mdm-2 was recently
found to interact physically with the other major tumour
suppressor retinoblastoma gene product pRb and to augment
proliferation by inducing transcription factor E2F (Martin et al,
1995; Xiao et al, 1995).
We were interested in the characterization of the expression
patterns of keratins and growth-control proteins in HPV-positive
cell lines derived from natural squamous intraepithelial lesions
(SILs) grown in a raft culture system. The study was performed to
evaluate whether any of the markers used in this study could be
used to demonstrate stepwise changes ofthe epithelium towards a
malignant phenotype in vitro.
MATERIALS AND METHODS
Cell lines
The two cell lines used in this study were derived from biopsy
specimens of an HPV 33-positive VAIN I lesion (UT-DEC-1) and
an HPV 16-positive VAIN II lesion (UT-DEC-2). The establish-
ment and characterization of these cell lines have been described
previously (Hietanen et al, 1992). At the time ofestablishment, the
cells were cultured as monolayers in Dulbecco's modified Eagle
medium (DMEM) supplemented with 1% non-essential amino
acids, 2 mM L-glutamine, 50 jg ml-1 streptomycin, 100 U ml1
penicillin, 1 gM dexamethasone, 10 ng ml-' human recombinant
epidermal growth factor (EGF) and 10% fetal calf serum. From
passage 19 onwards, UT-DEC-I cells showed independence of
growth factoraddition and were maintained in the medium without
dexamethasone or EGF. UT-DEC-2 required EGF addition to
support growth, but dexamethasone was not added after passage
20.
For the raft culture studies, cryopreserved cells were thawed
from early- and late-passage levels. The cells were allowed to
expand in a monolayer culture, one to three passages before raft
culture with a split ratio of 1:2. At this step, the medium was
changed to a low-calcium, serum-free keratinocyte medium, a
modification of MCDB 153 medium containing 50 jg ml-' bovine
pituitary extract and 5 ng ml-l EGF (Keratinocyte-SFM, Gibco,
Paisley, UK) to prevent the cells from further selection by differen-
tiation before raft culture. Late-passage UT-DEC-1 cells were
expanded in DMEM with 10% fetal bovine serum. Passage levels
ofthe cell lines were selected so thattheyrepresentedcells from the
time during the establishment of the cell line as well as cells after
extensive cell division. The passage 16 of UT-DEC-1 cells was
chosen because ofthe integration ofHPV 33 DNA into this cell line
and consequent chromosomal instability detected previously in p8
cells (Hietanen etal, 1992). To date, UT-DEC-I andUT-DEC-2 cell
lines have undergone 75 and 33 passages respectively.
Normal vaginal keratinocyte cultures were maintained in
Keratinocyte-SFM, and vaginal fibroblasts were grown in DMEM
supplemented with 1% non-essential amino acids, 2 mM L-glut-
amine, 50 jg ml-' streptomycin, 100 U ml-' penicillin and 10%
FBS. These normal cells were always used in the raft culture
experiments before their fourth passage.
Preparation of reorganized collagen gel
Vitrogen 100 collagen (Celtrix Pharmaceuticals, Santa Clara, CA,
USA) was mixed with lO x DMEM and neutralized by0.1 M sodium
hydroxide to pH 7.4 ± 0.2. Fibroblasts were suspended in the
collagen solution at a cell density of 3 x 105 cells per 0.7 ml. This
suspension was plated in 16-mmtissue culture dishes. The collagen-
fibroblast suspension was allowed to gel at 37°C for 1 h. Then,
the dishes were filled with DMEM supplemented with 5 jg ml-'
insulin (Sigma, St Louis, MO, USA), 10ng ml-' EGF (Boehringer
Mannheim, Germany), 0.5 jg ml-' hydrocortisone (Sigma) and
ascorbic acid 50jg ml-' (Sigma) and maintained at 37°C in an
atmosphere of 5% carbon dioxide at 90% relative humidity. The
medium was changed three times per week for 1 week.
Epidermal raft culture
Epithelial cells (2-3 x I05 cells per well) were added to the surface
ofthe fibroblast-collagen gels. At least three parallel raft cultures
were started from the same cells. In addition, both early- and late-
passage cells were analysed atleasttwice on the rafts. The medium
was changed to Green's medium and was identical for all indi-
vidual rafts. The medium consisted ofDMEM-Ham F12 3:1, 10%
FBS (Gibco, BRL), 4 mM glutamine, 5 jig ml-' insulin,
0.18 mM adenine (Sigma), 0.4 jg ml-' hydrocortisone, 0.1 nM
choleratoxin (Sigma) and 5 ng ml-1 EGF. After the cells had
reached confluence (usually in 2-4 days), the cultures were lifted
into the air-liquid interface using a stainless steel grid. The
medium was changed every 2-3 days. The medium was also
changed in all raft cultures on the day preceding harvesting.
The raft cultures were allowed to stratify for 10 days and then
harvested. Each raft was divided into two parts. One part was fixed
in buffered 10% formalin for 24 h and the other snap-frozen and
stored at -70°C for any future use. The formalin-fixed material
was embedded in paraffin and processed into 5-jm sections for
haematoxylin-eosin staining and immunohistochemistry.





Figure 1 Morphology of UT-DEC-i and UT-DEC-2 cell lines and normal vaginal keratinocytes in an organotypic raft culture. (A) UT-DEC-i, passage 8. The
polarity of the cells is slightly disturbed. No basal layer is seen. Some flattened cells are present in the superficial layer. (B) UT-DEC-i, passage 16: some
apoptotic cells showing shrinking and chromatin condensation into perinuclear crescents (arrow). Basophilic chromatin fragments are seen sporadically,
indicating the presence of apoptotic bodies (double arrow). Abnormal mitotic figures are also present (arrowhead). (C) UT-DEC-i, passage 63 cells from the
UT-DEC-i cell line. The morphology is consistent with a full-thickness intraepithelial neoplasia (VAIN Ill). (D) UT-DEC-2 cell line, passage 8. A cornified layer is
present with marked dyskeratosis. (E) UT-DEC-2, passage 29: colonies of cells invading the collagen matrix are seen, sometimes without connection to the
overlying epithelium. (F) Normal vaginal keratinocytes (H&E, original magnification x 250)
Immunohistochemistry
The expression of a panel of keratins, collagen IV, vimentin, p53,
p2lW'lw/CIPs, PCNA, mdm-2 and bcl-2 proteins was analysed in all
raft cultures. Table 1 shows the characterization and dilutions ofthe
monoclonal antibodies used forthe immunohistochemical stainings.
Formalin-fixed, paraffin-embedded sections placed on organo-
silane-coated slides were deparaffinized in xylene and rehydrated
with graded alcohol. Endogenous peroxidase activity was blocked
using 5% hydrogen peroxide for 5 min. The sections were first
incubated with 1.5% normal goat serum (Vector Laboratories,
Burlingame, CA, USA) for 15 min (to reduce the non-specific anti-
bodybinding), followedbyincubation withtheprimary antibody (in
blocking serum) overnight at +4°C. At the next step, the sections
were incubated with the secondary biotinylated antibody (anti-
mouse IgG, VectorLaboratories) for30 min, followedby incubation
with an avidin-biotin-peroxidase complex (Vectastain Elite ABC
Kit, Vector Laboratories) for 30 min. The immunoperoxidase reac-
tion was developed using 3,3'-diaminobenzidine (DAB; Sigma) for
5 min. Finally, the sections were counterstained with Maeyer's
haematoxylin, dehydrated and mounted with permount.
Positive and negative control sections were included in all stain-
ings (Table 1). Sections treated with the blocking serum without
primary antibodies served as negative controls. The intensity of
immunoreactivity was graded as negative (-), low (+), moderate
(++), strong (+++) or intense (++++). In addition, the distribution
of positive epithelial cells (scattered or even distribution) was
recorded separately.
PCR-SSCP
The PCR conditions for the p53 gene analysis and separation of
the PCR products have been described in more detail previously
(Hietanen et al, 1995). The analyses focused on exons 5-9 where
most p53 mutations in human cancers have been found. The
primers for amplification of pRB were chosen as previously
described and covered exons 12-22 (Weir-Thompson et al, 1991).
The DNA of UT-DEC-1 cells from passages 15 and 69 and UT-
DEC-2 cells from passages 8 and 30 were included in these
analyses. DNA from normal vaginal keratinocytes were used as
controls for the wild-typep53 andpRB.
RNA isolation and Northern blot analysis
Total RNA was isolated with Trizol (Life Technologies,
Gaithersburg, MD, USA) from UT-DEC-I and UT-DEC-2 grown
in monolayer cultures according to the manufacturer's protocol
based on the single-step method by Chomczynski and Sacchi
(1987). RNA samples were treated with RNAase-free DNAase
(Promega, Madison, WI, USA). Then, 20 ,ug of the RNA were
fractionated in 1.2% agarose gel and transferred to Hybond N+
membrane (Amersham) by vacuum transfer (VacuGene XL; LKB,
Bromma, Sweden) and immobilized by heating at 80°C. Filters
were hybridized to 32P-labelled RNA probes transcribed in vitro.
The HPV 16 E6-E7 probe (kindly provided by Dr M Durst,
German Cancer Research Center, Heidelberg, Germany) spans
from the up-stream regulatory region to the entire E6-E7 ORFs of
HPV 16. The cDNA for HPV 33 E6-E7 probe was synthesized
from total cellular RNA from p72 UT-DEC-1 cells with primers
spanning the HPV 33 E6-E7 region. A phosphorimager screen
(BioRad, Hercules, CA, USA) was exposed for 20 h, whereafter
specific mRNA hybridizations were detected (Molecular analyst,
BioRad). After exposure, the probe was stripped from the
membrane, and hybridization was then performed with a GAPDH
probe labelled with random priming.
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Anchorage-independent growth
UT-DEC-I and UT-DEC-2 cells were diluted to 04 cells per ml in
medium containing 0.33% SeaPlague agar (FMC Bioproducts,
Rockland, ME, USA), and 10 ml was plated on 85-mM dishes over
a layer of0.5% bottom agardissolved in the medium. The medium
consisted of DMEM with 10% FBS supplemented with 5 ng mln-
EGF and 0.5 gg ml-1 hydrocortisone. The medium was changed





Normal vaginal epithelial cells grown on the raft culture repro-
duced the growth pattern of a normal squamous epithelium,
although the epithelium remained thinner (Figure IF). Epithelial
cells were organized in a thin sheet of five to seven cell layers
thick. There was some tendency towards formation of a basal cell
layer, although not as regular as that normally found in vivo. There
was also a layer of flattened superficial cells, evidencing terminal
differentiation of normal vaginal keratinocytes in this raft culture
system.
UT-DEC-1
At early passage (p8), this premalignant squamous cell line grown
on theraft culture reproduced an epithelial pattern with some resem-
blance to that of a normal vaginal epithelium (Figure IA). The
epithelial sheet was slightly thicker, however, and the arrangement
(and polarity) of the cells was more disturbed, consistent with
intraepithelial neoplasia (i.e. the origin ofthe cell line). No evidence
of a basal cell layer could be found, but some tendency could be
seen towards formation ofa superficial layer offlattened cells.
Cells from p16, apart from their deranged epithelial architec-
ture, showed several morphological changes typical of apoptosis
(Figure iB): some cells showed chromatin condensation, some-
times with crescent formation at the border of the nuclear
membrane, and cellular shrinking. Occasionally, dense spheres
could also be detected in the extracellular space, typical of
apoptotic bodies (Figure iB). Several cells showing abnormal
mitoses were detected (Figure 1B). These changes were possibly
related to cell line 'crisis' before evolution ofimmortality.
Cells taken from a later passage (p63, p67 and p71) grew
notably differently. Epithelial thickness was greatly increased (up
to 20 layers). No polarity was detectable, and the morphology was
consistent with a full-thickness intraepithelial neoplasia (VAIN III,
Figure IC), although the cells originated from a VAIN I lesion.
There was no evidence of terminal differentiation as indicated by
the lack of any superficial cell layer. Compared with the early
cultures, the late-passage cells showed marked dedifferentiation.
UT-DEC-2
Cells taken at an early passage (p8) of this cell line produced an
epithelial structure of some eight to ten layers thick. The arrange-
ment and polarity ofcells were disturbed, but a comified layer was
still present with evidence of keratinization. Keratinization was
also detected in the intermediate layer, indicating dyskeratosis
(Figure ID). In some sections, smallerbasal-type cells were found,
whereas at other sites the epithelial cells showed a tendency to
penetrate into the underlying fibroblast-collagen matrix.
Cells from a later passage (p29) also formed a thin epithelium,
with even more pronounced abnormal morphological features
(Figure lE). The nuclei were markedly enlarged with a hyperchro-
matic staining pattern. The raft from this passage was character-
ized by a definite tendency of cells for penetration (as tiny buds)
into the underlying matrix (Figure 2 E2 and E4). Although origi-
nally derived from a VAIN II lesion, this cell line showed striking
in vitro morphological progression with features consistent with
an early invasive cancer.
Expression of keratins
In the rafts of normal vaginal keratinocytes, weak expression of
keratin 10 was seen infrequently only in some superficial epithe-
lial cells or was totally absent (Figure 2 Al). Immunostaining was
absent for K18 and weak for K19 (Figure 2 A3 and A4). Cells
strongly positive for keratin 17 were found in all epithelial layers
(Figure 2 A2). Collagen IV expression was detected as a faintband
underlying the basal cell layer, as a sign of these cells tending to
produce a structure resembling the basement membrane. Collagen
IV was not detected in any of the UT-DEC-I or UT-DEC-2 rafts
(Table 2).
In some p8 UT-DEC-I rafts, few faintly K0-positive cells were
detectable among the superficial cells, but the expression was
mostly absent (Figure 2 B1). K17 expression was faint but
detectable throughout the epithelium (Figure 2 B2). K18 was very
weakly expressed in scattered cells but mostly absent (Figure 2
B3), whereas moderate to strong K19 staining was detected
primarily in the basal cell layer (Figure 2 B4).
At later passages ofthe UT-DEC-I cell line (p63, p67 and p71),
K10 was absent (Figure 2 Cl). Intense K17 expression was
detected in most epithelial cells (Figure 2 C2). The cultures of
these late passages showed increasing intensity of K18 staining,
and positive cells were present in all layers (Figure 2 C3). K19
antibodies produced only weak signals in the entire epithelium
(Figure 2 C4).
When the p8 UT-DEC-2 cells were allowed to react with the
KIO (a marker ofepidermal keratinocyte differentiation) antibody,
moderate to strong staining was detected in the upper half of the
epithelium, but several cells were positive even in the vicinity of
the basal layer (Figure 2 Dl). The expression of KIO in early-
passage UT-DEC-2 rafts was clearly more intense than that in
early-passage UT-DEC-1 rafts. Strong K17 expression was
detected in all layers (Figure 2 D2). A very weak K18 staining was
seen in a few scattered cells (Figure 2 D3). K19 was moderately
expressed in all cell layers (Figure 2 D4).
In the raft cultures of p29 UT-DEC-2, staining for K10 was
weak (Figure 2 El). K17 was intensely expressed in all layers
(Figure 2 E2). K18 expression at p29 was much more intense than
that at p8 (Figure 2 E3). Clusters of cells invading the collagen
matrix also showed intense K18 staining. Similarly, K19 expres-
sion was increased and detected in mostepithelial layers as well as
in the invasive borders within the matrix (Figure 2 E4).
Another intermediate filament, vimentin, which is a marker for
mesenchymal cytoskeleton, has been shown to be expressed in
some transformed HPV 33-positive cell lines that have been exten-
sively passaged (Gilles et al, 1994). In the present study, only
fibroblasts in the collagen matrix stained with this antibody, but
not the epithelial UT-DEC-I and -2 cells (Table 2). The vimentin
staining was also performed on monolayer cultures of both cell
lines with similar negative results.











Figure 2 Immunohistochemical detection of keratins in normal vaginal keratinocytes and in UT-DEC-1 and UT-DEC-2 cell lines grown in an organotypic culture.
Keratin 10 (panel 1), keratin 17 (panel 2), keratin 18 (panel 3) and keratin 19 (panel 4). (A) Normal vaginal keratinocytes. (B) UT-DEC-1 cells at passage 8. (C) UT-
DEC-1 cells at passage 67. (D) UT-DEC-2 cells at passage 8. (E) UT-DEC-2 cells at passage 29 (Mayer's haematoxylin counterstain, original magnification x 250)
Table 2 Immunohistochemical detection of intermediate filaments and cell cycle-regulatory proteins in UT-DEC-1 (HPV 33 positive), UT-DEC-2 (HPV 16
positive) and normal vaginal keratinocytes in organotypic raft cultures
Passage of the cells
used in the raft culture K 10 K 17 K 18 K 19 Vimentin Collagen IV PCNA p53 mdm2 p21WAF1/CiP1 bcl-2
UT DEC-1
p8 ++ + +++ - - + ++ + -
p16 ++ + ++ ++ + -
p63 +I- +++ +++ +++ - - ++ + ++ + -
p67 .... ... ++ ++ + + + -
p71 - ++++ +++ + - - ++ + + + -
UT DEC-2
p8 ++ +++ + ++ - _ ++ + +++ ++ -
p29 + ++++ +++ ++++ - - ++ + ++ ++ -
Normal vaginal keratinocytes +/- +++ - + - + ++ + ++ +/-
-, No staining; +, weak; ++, moderate; +++, strong; ++++, intense staining.
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Figure 3 PCNA (panel 1), p53 (panel 2), mdm2 (panel 3) and p2iWAF1/Cip1 (panel 4) expression in normal vaginal keratinocytes, UT-DEC-1 and UT-DEC-2
rafts. (A) Normal vaginal keratinocytes. (B) UT-DEC-1 cells at passage 8. (C) UT-DEC-1 cells at passage 16. (D) UT-DEC-1 cells at passage 63. (E) UT-DEC-2
cells at passage 8. (F) UT-DEC-2 cells at passage 29. Mayer's haematoxylin counterstain, original magnification x 250 (A, B, E and F), x 100 (C and D, except
D2 at x 250)
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Figure 4 Expression of HPV 33 and 16 E6-E7 mRNA in UT-DEC-1 and UT-
DEC-2 cell lines at different passages. Total RNA (20 ,ug) was size-
fractionated on 1.2% agarose gel and transferred to membrane. The filters
were hybridized with [a-32P]CTP-labelled riboprobes for HPV 33 E6-E7 (UT-
DEC-1) and HPV 16 E6-E7 (UT-DEC-2). Images from phosphorimager files
are shown. In UT-DEC-1 cells the smaller predominant signal of
approximately 0.9 kb present in p12 cells is not seen at p70, where only a
band of approximately 3.3 kb is detected. In UT-DEC-2 cells the transcription
pattern was similar at p8 and p30
Expression of PCNA, p53, p21wAF1/cIP1 mdm-2 and bcl-2
The PCNA expression of normal vaginal keratinocytes was
confined to the basal cell layer (Figure 3 Al). UT-DEC-I and UT-
DEC-2 cell lines showed staining ofthe entire epithelial compart-
ment (Figure 3 B-F1). At higher passages (p63, p67, p71), PCNA
expression of UT-DEC-1 decreased slightly (Figure 3 DI and
Table 2), although the epithelium was some 20 layers thick, indi-
cating active proliferation ofthese cells. UT-DEC-2 cells intensely
expressed PCNA in full thickness of the epithelium at both early
and late passages (Figure 3 E-Fl and Table 2).
Both UT-DEC-1 and -2 cell lines and normal vaginal
keratinocytes showed a weak immunostaining for p53 (Figure 3
column 2). In organotypic cultures ofnormal cells, p53 expression
was restricted to the proliferative part of the epithelium (Figure 3
A2). This is consistent with the expression pattern found in biopsy
specimens of the healthy cervical epithelium (Kurvinen et al,
1996). Both UT-DEC-I and UT-DEC-2 expressed p53 only faintly
in scattered cells.
The nuclear staining for mdm-2 was more intense than p53 in
normal vaginal keratinocytes and UT-DEC-1 and -2 cells, but no
marked difference was seen between the early- and late-passage
rafts ofeither cell line (Figure 3 column 3 and Table 2). Therefore,
no sustained up-regulation of mdm-2 expression could be corre-
lated with the progression of these cell lines. This is consistent
with the recent study showing that mdm-2 amplification rarely
occurred in cervical carcinomas (Ikenberg et al, 1995).
Normal vaginal keratinocytes were negative or only faintly posi-
tive forp21WAF"lcipI, but occasionally somepositive cells were found
in more superficial layers (Figure 3 A4). UT-DEC-I and -2 cell lines
expressed p2IWAFl/CiPI at early passage, although p53 function was
supposedly abrogated by HPV E6 (Figure 3 column 4). When the
two cell lines were compared, the UT-DEC-2 cell line showed
clearly more intense staining. The expression was mainly localized
in the nuclei ofthe cells in the upperlayers ofthe epithelium, partic-
ularly in UT-DEC-2 p8 rafts (Figure 3 E4). At later passages, no
marked change could be detected in either cell line (Figure 3 F4).
The colonies invading the collagen matrix were negative.
The overall staining pattern in p16 UT-DEC-I rafts of all these
cell cycle proteins was in line with the other rafts from different
passage levels. However, a prominent feature was that PCNA and,
to a lesser degree p53, mdm2 and p21WAFlciPl immunostaining in
scattered cells was stronger than that found in any other rafts of
other passages ofthis cell line (Figure 3 C).
bcl-2 was not detected in any ofthe raft cultures, indicating that
any role that it may have in the establishment and progression of
these cell lines goes undetected by the present experimental
system (Table 2).
PCR-SSCP of the p53and pRBgenes
Polymerase chain reaction-single-strand conformation polymor-
phism (PCR-SSCP) analysis of p53 DNA showed that cells from
UT-DEC-1 (pI5, p69) and UT-DEC-2 (p8, p30) have banding
patterns identical with normal vaginal keratinocytes and CaSki
cells (known to contain wild-type p53), showing that these cell
lines have wild-type p53 (data not shown). In addition, the pRB
was wild type in these cell lines as detected by PCR-SSCP
analysis ofexons 12-22 (data not shown).
Northern blot analysis of HPV E6-E7 mRNA
HPV E6-E7 mRNA expression was studied by Northern blot
analysis. UT-DEC-I cells at pl2 showed a predominant transcript
of approximately 0.9 kb in size and three additional bands of
approximately 3.3-4.0 kb after long exposure of the phosphor-
imager screen. In the p70 cells, only an approximately 3.3-kb band
was detectable (Figure 4). With reverse transcription PCR, both
spliced E6*E7 transcripts and unspliced HPV 33 E6-E7 transcripts
capable ofencoding full-length E6 protein have been found in the
late-passage UT-DEC-I cells, although at low levels (Auvinen et
al, unpublished). We have previously shown the emergence of a
dominant cell population with hypodiploid DNA content in UT-
DEC-I after passage. In Southern blot, a molar decrease in a 2.0-
kb PstI fragment representing the L region ofthe HPV 33 genome
was observed when pl and p9 were compared (Hietanen et al,
1992). To find out possible changes at DNA level, a Southern
analysis forp22 andp70 cells was performed showing thatthe 2.0-
kb fragment was no longer detectable. Nor could we amplify the
late region of HPV 33 in p70 cells by PCR with Li- and L2-
specific primers (data not shown). These data indicate that selec-
tion ofa dominant cell population occurred during passaging.
Total mRNA from UT-DEC-2 p8 cells was hybridized with
HPV 16 E6-E7 probe and showed a predominant transcript of
approximately 2.2 kb and an additional 0.8-kb signal after long
exposure. These signals were also detected in p30 cells (Figure 4).
These data show that the HPV E6-E7 region is also expressed in
both these cell lines at the later passages.
Anchorage-independent growth
Neither cell line was able to grow in soft agar at early-passage
level (UT-DEC-1 plO and UT-DEC-2 p8). In contrast, UT-DEC-1
p72 cells formed colonies in soft agar with 4.5% efficiency.
Although UT-DEC-2 p32 cells had a high cloning efficiency on
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plastic, they formed colonies in soft agar at only 0.3% cloning effi-
ciency. Neither cell line was able to form colonies when they were
allowed to grow in soft agar without addition of EGF and hydro-
cortisone, indicating that the anchorage-independent growth was
hormone dependent.
DISCUSSION
In the present study an experimental system was established in
which cell lines derived from natural cancer precursor lesions of
the vagina were-followed for spontaneous changes resulting from
replicative aging in vitro. Both premalignant cell lines showed
changes in morphology and growth properties after passaging.
These changes indicate a progression towards a more transformed
phenotype. The growth on plastic of both cell lines became
hormone independent at later passages, but the anchorage-inde-
pendent growth was hormone dependent. Viral transcription is
known to be positively regulated by glucocorticoid hormones via
the up-stream regulatory region, which may at least partly explain
its contributing effect to the transformation (Gloss et al, 1987;
Mittal et al, 1993).
Both dysplastic cell lines and the normal vaginal keratinocytes
were obtained from vaginal fornices, which resemble the ectocer-
vical epithelium. In default of an existing thorough analysis ofthe
keratin expression in vaginal epithelium, published reports on
keratin expression from ectocervical epithelium were used for
comparative purposes. Nevertheless, VAIN originates in squa-
mous epithelium ofend stage differentiation while CIN originates
from reserve cells at the squamocolumnarjunction, indicating the
difference in the aetiology of these two lesions. KIO is a keratin
associated with normal epidermal keratinocyte differentiation and
only occasionally found in the ectocervical non-keratinizing
epithelium (Smedts et al, 1993). It has previously been shown that
keratin 1, which is coexpressed with K1O, is also related to the
differentiationprogramme ofneoplastic squamous cells (Cintorino
et al, 1990). The aberrant expression of K1O was seen throughout
the epithelium in early-passage UT-DEC-2 cells with marked
dyskeratosis and even in late passage cells, in contrast to the UT-
DEC-1 cell line and normal vaginal keratinocytes, in which K1O
was almost absent. This suggests that the differentiation of UT-
DEC-2 cells was shifted towards akeratinizing type ofepithelium.
Another keratin, K17, is only weakly expressed in a normal
ectocervical epithelium but detectable in immature metaplasia
(Smedts et al, 1993). Moreover, its increasing expression has been
found in cervical intraepithelial neoplasia (CIN) and cervical
cancer, as well as in skin cancer, in parallel with increasing
severity (Smedts et al, 1992a and b; Proby et al, 1993). In the
present study, an increase in K17 expression was seen in the later-
passage cells of both cell lines. However, normal vaginal
keratinocytes also expressed elevated levels of K17 keratin. It is
possible that these raft culture conditions affect keratin expression
of normal vaginal keratinocytes, making them more proliferative,
resembling hyperproliferative metaplastic cells expressing K17.
The mostinteresting keratins were K18 andK19, which are char-
acteristic of simple epithelia. Normally, K19 is expressed in the
basal layer of the ectocervical epithelium, but K18 occurs only
sporadically (Moll et al, 1982; Smedts et al, 1993). In the present
study, K19 was foundinbothpremalignant cell lines. However, K19
expression decreased in the UT-DEC-1 cell line but increased in the
UT-DEC-2 cell line towards later passages, indicating intrinsic
differences between cell lines. Recently, Moles et al (1994) found a
putative regulatory mechanism between p53 and K19. Using a raft
culture model, they observed that keratinocytes with wild-type p53
inhibited the expression of K19, whereas cells with aberrant p53
function showed abnormal K19 expression. Ifthis supposed associ-
ation explains the decrease ofK19 in late-passage UT-DEC-I cells,
it should imply that p53 activity increased. However, this seems
unlikely, based on theunaltered ordiminished expression ofthep53
target genes mdm2 andp2Jlwaf/CPl. Moreover, continuous transcrip-
tion of HPV 33 E6-E7 suggests that p53 function is continuously
affected. The effect ofHPV E6 on the function ofp53 is concentra-
tion dependent (Kessis etal, 1993; LechnerandLaimins, 1994), and
an attempt was made to analyse the HPV E6 protein levels in the
rafts of both cell lines, however the currently available antibodies
were not sufficiently specific to warnant conclusions.
The marked increase in aberrant K18 expression in both cell
lines at their later passages suggests a common underlying mecha-
nism. It has previously been shown that keratinocytes transfected
with oncogenic papillomaviruses show up-regulation of K8 or
K18 in a more transformed phenotype, but not early after immor-
talization (Merrick et al, 1992; Sun et al, 1993). The present data
show a similar tendency with naturally infected keratinocytes.
Moreover, the present data agree with the in vivo finding that
keratins 17 and 18 are associated with the loss ofan orderly differ-
entiated phenotype and may indicate the progressive nature ofthe
lesion (Syrjiinen et al, 1988; Smedts et al, 1992a).
PCNA is normally localized in the nucleus as an essential
component of the replication mechanism (Bravo et al, 1987;
Prelich et al, 1987). Besides its role in replication, it is directly
involved in nucleotide excision repair (Shivji et al, 1992), and
elevatedexpression is detected in response to DNAdamage in vivo
(Hall et al, 1993). PCNA is detected exclusively in the basal or
parabasal layer in a normal squamous epithelium, but in condylo-
mata and low-grade intraepithelial lesions, it is also expressed in
differentiating spinous cells (Demeter et al, 1994). In UT-DEC-1
andUT-DEC-2 rafts, PCNA was induced inthefull thickness ofthe
epithelium, indicating active proliferation even in the upper layers.
In HPV lesions, this induction has recently been associated with
HPV E7 protein that reactivates host DNA replication machinery
and PCNA to support viral replication (Cheng et al, 1995).
The immunostaining of UT-DEC-1 or UT-DEC-2 cells for
PCNA, p53, mdm-2 and p21WAFl/ciPl revealed no distinct changes,
which could be associated with the progressive alterations of the
phenotype of these cell lines. Apart from the relatively constant
expression of these cell cycle proteins at early and late passages,
the expression was strong, particularly for PCNA, in several cells
in UT-DEC-1 p16 rafts. This passage was chosen to evaluate
possiblechanges during the process ofevolving immortality ofthe
cell line. It is possible that the increased expression of these
markers in some cells reflects the ongoing process of selection of
cell clones with growth advantage. Despite the changes seen in
p16 rafts, the DNA content ofp73 UT-DEC-I cells, as determined
by flow cytometry, was unchanged compared with that ofp9-p29
cells (data not shown). Given this, itis interesting that the HPV 33
E6-E7 Northern blots representing cell populations of early and
late passages differed. The significance of this change for the
progression, however, is not yet known.
The finding that p21WAFl/CiPl immunostaining was moderate to
strong in rafts that contain cells with HPV E6 sequences capable
of abrogating the function ofp53 suggests that this cyclin-depen-
dent kinase inhibitor was induced by a p53-independent mecha-
nism. Although p53 is essential in the induction of p21WAFl/CiPl
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after DNA damage, it has been shown that p21WlAFciPl is associ-
ated with differentiation ofvarious cell types (Macleod et al, 1995;
Missero et al, 1995). In the present study, we could detect
p2lWAFI/CiPl expression localized mostly to the upper half of the
epithelium ofUT-DEC-2 p8 cells, and its expression was stronger
in UT-DEC-2 cells than in UT-DEC-1 cells. Based on the
morphology and KlO expression, the phenotype of early passage
UT-DEC-2 cells was more differentiated than that of UT-DEC-1
cells, although to the direction ofakeratinizing type ofepithelium.
Taken together, this suggests thatp21WAFl/ciPl is associated with the
more differentiated phenotype in these cell lines. Normal epithe-
lium in our study stained weaker, suggesting that some factor in
the cell lines may up-regulate the expression. Interestingly, in lung
carcinomas, p2WIAFl/CiPl was expressed at higher levels than in the
corresponding normal epithelium, and overexpression of
p21WAFl/ciPl was more frequent in well-differentiated tumours
(Marchetti et al, 1996).
In conclusion, two cell lines from natural squamous intraepithe-
lial lesions showed progressive changes in their phenotype after
replicative aging in vitro. These incuded changes in morphology
and keratin expression as well as a change in the transcription
pattern ofHPV 33 E6-E7 in the UT-DEC-1 cell line. However, no
significant changes could be observed in the expression ofthe cell
cycle-regulatory proteins explored in this study.
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